2m 2m 2m 2m 2m 2m 2m
ALPHA TEKNOVA (TKNO)
NASDAQ
$5.13-$0.05 (-1.06%)
Price as of Jun 03, 2026 4:27 PM EDT- $289.5MMarket Cap
- -9.91%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ALPHA TEKNOVA (TKNO)
$5.13-$0.05 (-1.06%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 40.5M +7.35% | 37.7M +2.89% | 36.7M -11.43% | 41.4M +12.27% | |
Cost of Revenue | 27.1M -11.26% | 30.5M +15.64% | 26.4M +10.21% | 23.9M +24.24% | |
Gross Profit | 13.4M +85.88% | 7.2M -29.77% | 10.3M -41.08% | 17.5M -0.82% | |
Sales and Marketing Expense | 6.8M +6.87% | 6.3M -32.26% | 9.3M +1.96% | 9.2M +142.28% | |
Research and Development Expense | -2.2M -20.37% | -2.8M -50.44% | -5.6M -28.05% | -7.7M +79.43% | |
Depreciation and Amortization Expense | 6.3M -3.59% | 6.6M +16.22% | 5.7M +78.83% | 3.2M +9.78% | |
Total Operating Expenses | 30.4M -8.87% | 33.4M -27.22% | 45.9M -31.69% | 67.1M +126.59% | |
Operating Profit | -17.0M -35.07% | -26.1M -26.48% | -35.6M -28.39% | -49.7M +313.55% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -710,000 +3.35% | -687,000 -17.53% | -833,000 N/A | N/A N/A | |
Interest Income and Expense and Net | -710,000 +3.35% | -687,000 -17.53% | -833,000 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | -225,000 -67.25% | -687,000 -54.65% | -1.5M -665.30% | 268,000 +142.61% | |
Income before Taxes | -17.2M -35.90% | -26.8M -27.63% | -37.1M -24.93% | -49.4M +290.84% | |
Income Taxes | 58,000 +165.91% | -88,000 -70.47% | -298,000 -84.50% | -1.9M -32.15% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -17.3M -35.47% | -26.7M -27.28% | -36.8M -22.52% | -47.5M +384.22% | |
Net Income from Continuing Operations Applicable to Common | -17.2M -35.90% | -26.8M -27.63% | -37.1M -24.93% | -49.4M +403.84% | |
Basic EPS and Net Income | -0.32 -43.86% | -0.57 -50.86% | -1.16 -31.36% | -1.69 +177.05% | |
Diluted EPS and Net Income | -0.32 -43.86% | -0.57 -50.86% | -1.16 -31.36% | -1.69 +177.05% | |
Basic Weighted Average Shares | 53.5M +14.41% | 46.7M +46.91% | 31.8M +13.30% | 28.1M +74.57% | |
Diluted Weighted Average Shares | 53.5M +14.41% | 46.7M +46.91% | 31.8M +13.30% | 28.1M +74.57% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.9M +59.44% | 3.7M -86.98% | 28.5M -32.56% | 42.2M -51.74% | |
Short-Term Investments | 15.4M -42.20% | 26.7M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 21.3M -29.80% | 30.4M +6.71% | 28.5M -32.56% | 42.2M -51.74% | |
Total Current Assets | 34.5M -19.32% | 42.8M -6.32% | 45.7M -25.32% | 61.1M -39.59% | |
Accumulated Depreciation | 17.4M +41.88% | 12.2M +62.65% | 7.5M +66.55% | 4.5M +82.77% | |
Property and Plant and Equipment and Net | 41.7M -8.79% | 45.8M -9.16% | 50.4M -2.35% | 51.6M +73.02% | |
Total Long-Term Assets | 1.3M -7.02% | 1.4M -25.38% | 1.9M -17.76% | 2.3M +1,151.11% | |
Total Assets | 103.6M -12.79% | 118.8M -7.64% | 128.6M -15.55% | 152.3M -8.56% | |
Income Taxes Payable | 879,000 +6.29% | 827,000 -10.01% | 919,000 -24.86% | 1.2M -61.21% | |
Total Short-Term Debt | 0 -100.00% | 4.0M -59.55% | 10.0M 0.00% | 10.0M N/A | |
Total Current Liabilities | 7.5M -32.77% | 11.2M +26.32% | 8.9M -18.39% | 10.9M +40.45% | |
Total Long-Term Debt | 13.1M +38.97% | 9.4M -28.74% | 13.3M -39.70% | 22.0M +85.14% | |
Total Long-Term Liabilities | 28.2M +8.35% | 26.0M -14.80% | 30.5M -28.31% | 42.5M +134.01% | |
Total Liabilities | 34.8M -4.31% | 36.4M -5.64% | 38.6M -26.40% | 52.4M +124.71% | |
Retained Earnings | -135.8M +14.56% | -118.5M +29.14% | -91.8M +66.87% | -55.0M +629.72% | |
Total Stockholders Equity | 68.8M -16.53% | 82.4M -8.49% | 90.0M -9.86% | 99.9M -30.25% | |
Total Shares Outstanding | 53.6M +0.29% | 53.4M +30.93% | 40.8M +44.76% | 28.2M +0.60% | |
Cash Flow | |||||
Cash from Operating Activities | -8.6M -30.22% | -12.4M -34.14% | -18.8M -31.34% | -27.4M +202.13% | |
Capital Expenditures | 1.1M +2.04% | 1.1M -85.82% | 7.9M -71.81% | 28.1M +41.62% | |
Cash from Investing Activities | 10.7M +139.23% | -27.3M +252.53% | -7.7M -72.51% | -28.1M +60.66% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 151,000 -98.99% | 14.9M +16.34% | 12.8M +24.66% | 10.3M -90.73% | |
Financials Ratio | |||||
Gross Margin | 33.17% +73.15% | 19.16% -31.74% | 28.07% -33.48% | 42.19% N/A | |
Operating Margin | -41.90% -39.52% | -69.27% -28.55% | -96.94% -19.14% | -119.89% N/A | |
Return on Assets | -15.52% -28.21% | -21.62% -17.44% | -26.19% -12.05% | -29.78% N/A | |
Return on Equity | -22.83% -26.39% | -31.02% -19.91% | -38.73% -0.83% | -39.05% N/A | |
Revenue Growth | 7.35% +154.19% | 2.89% +125.30% | -11.43% -193.18% | 12.27% N/A | |
Current Ratio | 4.58 +20.01% | 3.82 -25.84% | 5.14 -8.49% | 5.62 N/A | |
Cash Ratio | 0.78 +137.19% | 0.33 -89.70% | 3.21 -17.36% | 3.88 N/A | |
Debt-to-Equity Ratio | 0.19 +16.55% | 0.16 -36.60% | 0.26 -19.34% | 0.32 N/A | |
Debt-to-Assets Ratio | 0.13 +11.53% | 0.11 -37.17% | 0.18 -13.90% | 0.21 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow